Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

MD Anderson Cancer Center Acquires Two Elekta Versa HD Systems

The University of Texas MD Anderson Cancer Center (Houston, Texas) has purchased two Elekta Versa HD™ linear accelerators.

PSA screening launches cascade of treatment, complications

Advancing age and worsening comorbidity were associated with fewer prostate biopsies after abnormal PSA screening results; however, biopsy-detected cancer often led to treatment regardless of age, comorbidity or cancer status, according to a study published online April 15 in the Journal of the American Medical Association.

Prostate Cancer Patient Receives First Treatment Using Latest Version of Vitesse Real-Time Brachytherapy Planning System from Varian Medical Systems

A prostate cancer patient has become the first person in the world to be treated using the latest version of Varian's Vitesse™ real time planning solution for planning and performing advanced high-dose-rate (HDR), ultrasound-guided brachytherapy treatments. The treatment took place at the Levine Cancer Institute in Charlotte, North Carolina.

NLST false-positive rate ranged from 4 to 69 percent

There was considerable variability in false-positive rates (FPRs) and nodule counts across radiologists in the National Lung Screening Trial (NLST), according to a study published online April 16 in Radiology.

Elekta Receives U.S. FDA 510(k) Clearance Following Launch of New Versa HD Radiation Therapy System for Cancer Treatment

Elekta recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to begin shipping and installation of all components of the Versa HD™ system within the United States.

U.K. Clinic Anticipating New Era of Radiotherapy Speed and Precision with Elekta’s New Versa HD System

Featuring a revolutionary combination of speed and accuracy, Elekta’s new Versa HD™ system will help clinicians at The Christie NHS Foundation Trust (Withington, Manchester) maximize the precision of therapeutic beams on the tumor target, while also accelerating radiation delivery to new levels.

Lilly Debuts Early Oncology Pipeline Data At AACR Annual Meeting

Eli Lilly and Company (NYSE: LLY) unveiled data from four key molecules that represent the next generation of its oncology pipeline at the American Association for Cancer Research (AACR) Annual Meeting held in Washington, D.C. from April 6-10.

CANARY in the reading room: Software characterizes lung nodule risk

Newly developed software offers a method to assess high-resolution chest CT scans and noninvasively characterize pulmonary nodules, according to a pilot study published in the April issue of the Journal of Thoracic Oncology.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.